Avery Dennison (AVY)
(Delayed Data from NYSE)
$214.79 USD
-5.77 (-2.62%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $214.98 +0.19 (0.09%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$214.79 USD
-5.77 (-2.62%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $214.98 +0.19 (0.09%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum B VGM
Zacks News
Here's Why You Should Dump Avery Dennison From Your Portfolio
by Zacks Equity Research
Higher debt levels, raw material inflation will impact Avery Dennison's (AVY) results in the near-term.
5 Top Stocks to Buy With Solid Earnings Acceleration
by Tirthankar Chakraborty
If the rate of a company's quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be referred to as earnings acceleration.
Donaldson (DCI) Q3 Earnings Trump Estimates, View Upbeat
by Zacks Equity Research
Donaldson's (DCI) third-quarter fiscal 2018 adjusted earnings beat the Zacks Consensus Estimate by a penny on the back of impressive growth in revenues and favourable market conditions.
Actuant (ATU) Gains From Growth Efforts Amid Cost Concerns
by Zacks Equity Research
Actuant (ATU) looks good on the back of solid industrial sales, acquisitions and restructuring moves, but soaring costs and weak energy business remain causes of concern.
Avery Dennison (AVY) Up 1.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Avery Dennison (AVY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: Insight, PetMed, Avery and TriplePoint
by Zacks Equity Research
Zacks.com featured highlights include: Insight, PetMed, Avery and TriplePoint
Avery Dennison (AVY): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Avery Dennison (AVY) is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective.
4 Top Stocks to Buy for Solid Earnings Acceleration
by Tirthankar Chakraborty
If the rate of a company's quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be referred to as earnings acceleration
Pentair Riddled by Cost Inflation, Post Separation Concerns
by Zacks Equity Research
Pentair's (PNR) margins in fiscal 2018 will be impacted by higher material and other costs. Also, risks pertaining to the separation of the Electrical business add to the concerns
Tetra Tech (TTEK) Beats on Q2 Earnings & Revenues, Ups View
by Zacks Equity Research
Tetra Tech's (TTEK) impressive second-quarter fiscal 2018 results can be attributed to broad based growth led by increased work for its U.S. state and local clients.
Avery Dennison (AVY) Q1 Earnings & Sales Beat Estimates
by Zacks Equity Research
Avery Dennison (AVY) expected to benefit from the multi-year restructuring plan, comprising the consolidation of LGM's European footprint, in 2018.
Avery Dennison (AVY) Q1 Earnings and Sales Beat, View Up
by Zacks Equity Research
Avery Dennison (AVY) is anticipated to benefit in 2018 from a multi-year restructuring plan.
What's in the Cards for Avery Dennison (AVY) in Q1 Earnings?
by Zacks Equity Research
Avery Dennison (AVY) is likely to break its earnings streak in Q1 due to higher raw material costs.
Zacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied Materials
by Zacks Equity Research
Zacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied Materials
5 Top Dividend Growth Stocks to Buy Amid Market Turmoil
by Sweta Killa
A history of year-over-year dividend growth leads to a healthy portfolio with greater scope of capital appreciation.
Reasons to Add Avery Dennison (AVY) to Your Portfolio Now
by Zacks Equity Research
Upbeat guidance, price performance ahead of the industry and other factors make Avery Dennison (AVY) a must-add to your portfolio. Read on to find out.
Here's Why You Should Hold on to TriMas (TRS) Stock for Now
by Zacks Equity Research
TriMas (TRS) expects to benefit from focus on TriMas Business Model, segment restructuring and successful Aerospace business despite elevated steel prices.
Avery Dennison (AVY) is Oversold: Can It Recover?
by Zacks Equity Research
Avery Dennison Corporation (AVY) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Zacks.com highlights: Avery Dennison, Owens Corning, Columbia Sportswear, Intel and H&E Equipment Services
by Zacks Equity Research
Zacks.com highlights: Avery Dennison, Owens Corning, Columbia Sportswear, Intel and H&E Equipment Services
Avery Dennison (AVY) Gains 43% in a Year: What's Driving It?
by Zacks Equity Research
Forecast-topping Q4 earnings performance, upbeat guidance, bookings and backlog strength contribute to the rally in Avery Dennison's (AVY) shares.
5 Dividend Stocks With Growth Potential to Bet On
by Sweta Killa
Dividend growth stocks are likely to emerge winners amid a volatile market.
6 Top-Ranked Stocks That Can Make You Jeff Bezos Like Rich
by Aniruddha Ganguly
We pick six stocks that have significant growth prospects and can enhance investors' wealth like Amazon CEO Jeff Bezos.
Donaldson (DCI) Q2 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Donaldson's (DCI) second-quarter fiscal 2018 adjusted earnings lagged the Zacks Consensus Estimate by a penny, while revenues beat the same.
Reasons to Add Milacron (MCRN) Stock to Your Portfolio Now
by Zacks Equity Research
Milacron's (MCRN) prospects remain bright on the back of solid order growth, expansion of geographic footprint as well as cost-reduction initiatives
Flowserve (FLS) Q4 Earnings Miss Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Flowserve's (FLS) fourth-quarter 2017 adjusted earnings fall short of the Zacks Consensus Estimate by 3.8% while revenues beat the same.